Yuen Yuen Ang, author of China’s Gilded Age: The Paradox of Economic Boom and Vast Corruption, looks at the global impact of China’s rise and how corruption has evolved over time How has China managed to grow so fast for so long despite corruption on a large scale? That is the question Yuen Yuen Ang […]
The COVID-19 crisis turned taking online classes from being a mere option to becoming an absolute necessity. What does this mean for businesses working in the education technology sector?
Chinese pet owners are increasingly spending money on products and services to improve the lives of their beloved animal companions. Pampered pooches have become beloved members of many Chinese families, and the pet care industry is booming as a result.
In this interview, Roseann Lake explores gender roles in China and how these so-called “leftover women” are shaping the country’s economic future.
In this wide-ranging discussion, Schneider discusses the complex impact Chinese and other Asian art collectors are having on the global art market, and ways in which smaller Chinese galleries can survive Western competition.
When Chinese collectors and dealers began buying Western art in the late 90s, they confronted a market dominated by an oligopoly of auction houses and dealers that were concentrated in New York and London. Twenty years later, not much has changed.
How is China’s bulging waistline impacting the economy and the country’s health care system?
China’s controversial social credit system is already being trialed in many cities in the country. What has its effect been and what can be expected in the future?
When Dame Barbara Woodward was named British Ambassador to China in February 2015, she became the first woman ever to hold this position. Conscious of her status as a trailblazer and role model, Ambassador Woodward has made a special commitment to promoting gender equality since assuming office.
After a stream of scandals and medical incidents, the Chinese public appears to be losing faith in drugs made in China. What are the implications for domestic and international pharmaceutical companies?